Rapport Therapeutics Inc....

NASDAQ: RAPP · Real-Time Price · USD
14.66
-0.28 (-1.87%)
At close: Aug 15, 2025, 3:59 PM
14.57
-0.61%
After-hours: Aug 15, 2025, 05:51 PM EDT

Rapport Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-78.31M -34.79M -10.65M
Depreciation & Amortization
839K 112K 16.36K
Stock-Based Compensation
10.23M 3.52M 609.82K
Other Working Capital
-2.07M 1.8M 1.49M
Other Non-Cash Items
4.82M 1.32M 5.3M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-2.42M 2.65M 1.49M
Operating Cash Flow
-64.83M -27.18M -3.24M
Capital Expenditures
-2.4M -1.64M -284K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-380.74M -77.22M n/a
Sales Maturities Of Investments
209.8M n/a n/a
Other Investing Acitivies
3.21M n/a -5M
Investing Cash Flow
-170.14M -78.86M -5.28M
Debt Repayment
n/a n/a 7.9M
Common Stock Repurchased
n/a -4K n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
7K -134K n/a
Financial Cash Flow
221.63M 145.14M 39.69M
Net Cash Flow
-13.34M 39.09M 31.16M
Free Cash Flow
-67.23M -28.82M -3.53M